M-POWER Feasibility Study

Status Completed

Clinical Trial Summary

The purpose of this study is to test a new weight loss intervention designed for cancer survivors who have heart disease or cardiometabolic conditions. The investigators want to determine whether this study is feasible and acceptable to participants. The investigators also want to learn more about how cancer survivors take their medications.

Clinical Trial Description

The purpose of this study is to test a new weight loss intervention designed for cancer survivors. The investigators want to determine whether this approach to weight loss is feasible and acceptable to cancer survivors. All participants in the study will receive free behavioral telephone-based weight loss management in the Department of Preventive Medicine at Northwestern University. Participants must be willing and able to use their smartphone with Bluetooth and their WiFi to download Apps, set up a Fitbit account and a Google account if not already set up. Participants will use their smartphone to record food intake & physical activity over an 8 week weight loss program. This program includes recruitment of a "Buddy" that the participant will choose to support you during the 8 week study. All participants will be asked to download a study application to use to record dietary intake each day during a "Run-In Week.". Eligible participants will then receive an 8-week weight loss program, including individual weekly sessions with health coaches. The investigators will also ask participants to complete both a baseline and follow-up session with study staff. If permitted by current university policies, these sessions will be held at the offices on Northwestern University's Chicago campus. Otherwise, these sessions will be conducted remotely via Zoom videoconference. If this is the case, as a privacy safeguard, the waiting room feature will be applied so that study staff can control who is admitted into the meeting. We expect that the participants will be in this research study for about 10 weeks. The primary risk of participation is muscle soreness or injury from increased physical activity, as well as feelings of hunger from making changes to diet. The main benefit is that a participant may experience positive changes to their health and mood based on the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05921565
Study type	Interventional
Source	Northwestern University
Contact
Status	Completed
Phase	N/A
Start date	March 11, 2019
Completion date	November 8, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04817176` - MI-CBT Adherence Program for Lifestyle Interventions in Older Adults	Early Phase 1
Completed	`NCT03044145` - The Cultural Formulation Interview-Engagement Aid	N/A
Completed	`NCT03231020` - Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study
Completed	`NCT03402802` - Steroid Eyedrop Adherence After Trabeculectomy
Recruiting	`NCT03625674` - Impact of Stigma on Compliance to Medication in Functional Dyspepsia	N/A
Active, not recruiting	`NCT04424368` - Remote Monitoring System for Patients, Who Had Myocardial Infarction	N/A
Completed	`NCT04169646` - Prevention and Intervention of Neck Pain in Swiss Office-Workers	N/A
Recruiting	`NCT03721445` - Could HRV be a Valuable Predictor for CPAP Adherence?
Recruiting	`NCT05832008` - Increasing Adherence to Lung Cancer Screening	N/A
Completed	`NCT03484637` - Response Evolution Chart
Completed	`NCT03710213` - Automated Navigation to Improve Outpatient Colonoscopy Adherence	N/A
Active, not recruiting	`NCT04166422` - Virtual Reality and Video Games in Cardiac Rehabilitation Programs	N/A
Terminated	`NCT03109743` - Group Clinical Visit Adherence Intervention for HIV+ Women of Color	N/A
Completed	`NCT03883282` - Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor
Recruiting	`NCT05709145` - Written Recommendation to Improve Adherence in Poor Bowel Preparation	N/A
Not yet recruiting	`NCT06195839` - Building Engagement Using Financial Incentives Trial - Hypertension	N/A
Recruiting	`NCT05159089` - Physical Activity Drop-out Ratio in Patients Living With Type 2 Diabetes	N/A
Completed	`NCT06068699` - Postcards to Improve Remote Monitoring Adherence Among Veterans	N/A
Completed	`NCT03340428` - Post-release Retention in HIV Care for Ex-inmates in South Africa	N/A
Recruiting	`NCT05613010` - Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

M-POWER Feasibility Study — M-POWER

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms